These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19450979)

  • 41. An atypical IRES within the 5' UTR of a dicistrovirus genome.
    Roberts LO; Groppelli E
    Virus Res; 2009 Feb; 139(2):157-65. PubMed ID: 18755228
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phosphorothioate antisense oligodeoxynucleotides capable of inhibiting hepatitis C virus gene expression: in vitro translation assay.
    Seki M; Honda Y
    J Biochem; 1995 Dec; 118(6):1199-204. PubMed ID: 8720135
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of new triplet forming artificial nucleobases as RNA ligands directed towards HCV IRES IIId loop.
    Safir Filho M; Martin AR; Benhida R
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1780-1783. PubMed ID: 28274634
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quinoxaline derivatives disrupt the base stacking of hepatitis C virus-internal ribosome entry site RNA: reduce translation and replication.
    Chakraborty J; Kanungo A; Mahata T; Kumar K; Sharma G; Pal R; Ahammed KS; Patra D; Majhi B; Chakrabarti S; Das S; Dutta S
    Chem Commun (Camb); 2019 Nov; 55(93):14027-14030. PubMed ID: 31690898
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased inhibitory ability of conjugated RNA aptamers against the HCV IRES.
    Kikuchi K; Umehara T; Nishikawa F; Fukuda K; Hasegawa T; Nishikawa S
    Biochem Biophys Res Commun; 2009 Aug; 386(1):118-23. PubMed ID: 19501043
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activity of core-modified 10-23 DNAzymes against HCV.
    Robaldo L; Berzal-Herranz A; Montserrat JM; Iribarren AM
    ChemMedChem; 2014 Sep; 9(9):2172-7. PubMed ID: 25079672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional analyses of RNA structures shared between the internal ribosome entry sites of hepatitis C virus and the picornavirus porcine teschovirus 1 Talfan.
    Chard LS; Kaku Y; Jones B; Nayak A; Belsham GJ
    J Virol; 2006 Feb; 80(3):1271-9. PubMed ID: 16415004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Molecular environment of the IIId subdomain of the IRES element of hepatitits C virus RNA on the human 40S ribosomal subunit].
    Babaĭlova ES; Graĭfer DM; Malygin AA; Shatskiĭ IN; Shtal I; Karpova GG
    Bioorg Khim; 2009; 35(1):103-12. PubMed ID: 19377528
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain.
    Seth PP; Miyaji A; Jefferson EA; Sannes-Lowery KA; Osgood SA; Propp SS; Ranken R; Massire C; Sampath R; Ecker DJ; Swayze EE; Griffey RH
    J Med Chem; 2005 Nov; 48(23):7099-102. PubMed ID: 16279767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-throughput screening of HCV RNA replication inhibitors by means of a reporter replicon system.
    Hao W; Duggal R
    Methods Mol Biol; 2009; 510():243-50. PubMed ID: 19009266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Specific regulatory inhibition of transfected HepG(2) with HCV 5'NCR by antisense phosphorothioate oligodeoxynucleotides].
    Wang S; Wang X; Guan W; Li M
    Zhonghua Gan Zang Bing Za Zhi; 2000 Oct; 8(5):288-90. PubMed ID: 11058954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A human cell-derived in vitro coupled transcription/translation system optimized for production of recombinant proteins.
    Mikami S; Kobayashi T; Masutani M; Yokoyama S; Imataka H
    Protein Expr Purif; 2008 Dec; 62(2):190-8. PubMed ID: 18814849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nucleic-acid-based antiviral agents against positive single-stranded RNA viruses.
    Lim TW; Yuan J; Liu Z; Qiu D; Sall A; Yang D
    Curr Opin Mol Ther; 2006 Apr; 8(2):104-7. PubMed ID: 16610761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and HCV inhibitory properties of 9-deaza- and 7,9-dideaza-7-oxa-2'-C-methyladenosine.
    Butora G; Olsen DB; Carroll SS; McMasters DR; Schmitt C; Leone JF; Stahlhut M; Burlein C; Maccoss M
    Bioorg Med Chem; 2007 Aug; 15(15):5219-29. PubMed ID: 17521911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. siVirus: web-based antiviral siRNA design software for highly divergent viral sequences.
    Naito Y; Ui-Tei K; Nishikawa T; Takebe Y; Saigo K
    Nucleic Acids Res; 2006 Jul; 34(Web Server issue):W448-50. PubMed ID: 16845046
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine.
    Smith DB; Kalayanov G; Sund C; Winqvist A; Pinho P; Maltseva T; Morisson V; Leveque V; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M
    J Med Chem; 2009 Jan; 52(1):219-23. PubMed ID: 19055482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of an antisense RNA delivery system using conjugates of the MS2 bacteriophage capsids and HIV-1 TAT cell-penetrating peptide.
    Wei B; Wei Y; Zhang K; Wang J; Xu R; Zhan S; Lin G; Wang W; Liu M; Wang L; Zhang R; Li J
    Biomed Pharmacother; 2009 May; 63(4):313-8. PubMed ID: 18823738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of Japanese encephalitis virus replication by peptide nucleic acids targeting cis-acting elements on the plus- and minus-strands of viral RNA.
    Yoo JS; Kim CM; Kim JH; Kim JY; Oh JW
    Antiviral Res; 2009 Jun; 82(3):122-33. PubMed ID: 19428603
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Activity of specific deoxyribozymes to cleave hepatitis C virus RNA in vitro].
    Yu YC; Gu CH; Wang SQ; Mao Q; Chen ZB; Liu HL
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):156-8. PubMed ID: 12681063
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oncostatin M synergistically inhibits HCV RNA replication in combination with interferon-alpha.
    Ikeda M; Mori K; Ariumi Y; Dansako H; Kato N
    FEBS Lett; 2009 May; 583(9):1434-8. PubMed ID: 19332062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.